CELIXIR
Celixir is a developer of regenerative medicines created to change the lives of patients in need. The company's medicines consists of iMP cells, platelet lysate and PML cells to treat patients with ischaemic heart disease, injured tendons near the surface of the skin and mild to moderate heart failure respectively, enabling medical researchers to discover breakthrough medicines that aim to change the standard of medical care for patients.
CELIXIR
Industry:
Biotechnology Health Care Medical
Founded:
2009-01-01
Address:
Cardiff, Cardiff, United Kingdom
Country:
United Kingdom
Website Url:
http://www.celixir.com
Total Employee:
11+
Status:
Active
Total Funding:
2.62 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-05-01 | Desktop Genetics | Desktop Genetics acquired by Celixir | N/A |
Investors List
Angels 5K
Angels 5K investment in Venture Round - Celixir
Official Site Inspections
http://www.celixir.com Semrush global rank: 4.12 M Semrush visits lastest month: 2.92 K
- Host name: 185-151-30-187.ptr4.stackcp.net
- IP address: 185.151.30.187
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Celixir"
Celixir - Crunchbase Company Profile & Funding
Celixir is a developer of regenerative medicines created to change the lives of patients in need. The company's medicines consists of iMP cells, platelet lysate and PML cells to treat patients …See details»
Celixir - LinkedIn
Celixir (formerly known as Cell Therapy Ltd.) is a private British regenerative medicine company that discovers and develops life-saving and life-altering regenerative medicines for patients …See details»
Celixir Company Profile 2024: Valuation, Funding & Investors
Celixir General Information Description. Developer of cell and gene therapies designed to treat cancer, heart failure, and other incurable diseases. The company's medicines consist of iMP …See details»
Celixir
All rights reserved ... Skip to contentSee details»
Celixir - Products, Competitors, Financials, Employees, …
Celixir is a private British company that focuses on regenerative medicine within the healthcare industry. The company's main offerings include the discovery and development of …See details»
Celixir Company Profile - Office Locations, Competitors ... - Craft
Celixir has 5 employees at their 1 location and $2.64 m in total funding,. See insights on Celixir including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Celixir (fka Cell Therapy) - VentureRadar
We are focussed on developing cell and gene therapies to treat incurable or poorly treated diseases including cancer and heart failure. Innovation is at the heart of Celixir. Our unique …See details»
Celixir provides update on ongoing clinical programme with lead ...
Jul 6, 2020 Celixir Ajan Reginald, CEO +44 1789 269 838 [email protected]. Consilium Strategic Communications Mary Jane Elliott / Sukaina Virji / Angela Gray +44 (0)20 3709 5700 …See details»
Celixir - Funding, Financials, Valuation & Investors - Crunchbase
Celixir is a unique technology platform drives in-house discovery and manufacturing. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ... How …See details»
Celixir's Acquisition by Ashington Innovation - LifeSci Voice
Aug 19, 2023 The inception of Celixir dates back to 2009 when these two visionaries established the company. Celixir’s primary focus centered on an allogeneic cell therapy approach …See details»
Celixir provides update on ongoing clinical programme with
Jul 6, 2020 Celixir Ajan Reginald, CEO +44 1789 269 838 [email protected]. Consilium Strategic Communications Mary Jane Elliott / Sukaina Virji / Angela Gray +44 (0)20 3709 5700 …See details»
Celixir - Contacts, Employees, Board Members, Advisors & Alumni
Celixir is a unique technology platform drives in-house discovery and manufacturing.See details»
UK cell therapy biotech rides SPAC track out of the graveyard
Aug 17, 2023 The deal is nothing short of a complete resuscitation of Celixir. In March 2023, the company reported having roughly 285,000 pounds ($363,500) on hand, with more than 10 …See details»
Celixir: Regenerative Medicine for Life - IntelligentHQ
The company has at least 20 tissue-specific regenerative medicines that are in various stages of development. Celixir claims that this is “unprecedented in the field of regenerative medicine.” …See details»
CELIXIR: CTA approval for potentially pivotal HeartcelTM
Celixir Ajan Reginald +44 1789 269 838 [email protected]. Consilium Strategic Communications Mary Jane Elliott / Ivar Milligan / Sukaina Virji +44 (0)20 3709 5700 celixir@consilium …See details»
Celixir’s cell therapy gets green light for heart failure trial
Jan 9, 2018 The Medicines and Healthcare Products Regulatory Agency has issued a green light allowing Celixir to carry out a potentially pivotal Phase IIb human clinical trial with its stem …See details»
CELIXIR: CTA approval for potentially pivotal HeartcelTM Phase IIb …
Jan 8, 2018 CTA approval for potentially pivotal Heartcel TM Phase IIb trial - Adult heart failure trial to complete in 2020 with potential market entry in 2021 - Trial to be conducted at Imperial …See details»
Research programme: cell therapies - Celixir - AdisInsight - Springer
Celixir (formerly Cell Therapy Limited) is developing allogeneic cell therapies for the treatment of type I diabetes, cancer and skin disorders. The company is ... If your organization has a …See details»
Celixir publishes positive study results for potential - GlobeNewswire
May 13, 2019 Celixir Ajan Reginald, CEO +44 1789 269 838 [email protected]. Consilium Strategic Communications Mary Jane Elliott / Sukaina Virji / Angela Gray +44 (0)20 3709 5700 …See details»
Requiem for Celixir - For Better Science
Jun 30, 2021 Celixir, formerly Cell Therapy Ltd, once the pride of British science ingenuity, is now virtually defunct.Both founders, the Nobel Prize winner Sir Martin Evans and the struck-off …See details»